Bremen De Mucio

Bremen De Mucio

Auto-generated profile, based on publicly available information

Bremen De Mucio

Women and Reproductive Health, Latin American Center for Perinatology, Pan American Health Organization (PAHO)/World Health Organization (WHO), Washington, DC 20037, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 August 2015 in BJOG: An International Journal of Obstetrics & Gynaecology
Verified
Journal Article
Open access
PDF file
JSJp Souza
Jp Souza
ABAP Betran
AP Betran
ADAlexandre Dumont
Alexandre Dumont
BMB de Mucio
B de Mucio
CPCm Gibbs Pickens
Cm Gibbs Pickens
AGAm Gülmezoglu
Am Gülmezoglu
Objective: To generate a global reference for caesarean section (CS) rates at health facilities.Design: Cross‐sectional study.Setting: Health facilities from 43 countries.Population/Sample: Thirty eight thousand three hundred and twenty‐four women giving birth from 22 countries for model building and 10 045 875 women giving birth from 43 countries for model testing.Methods: We hypothesised that mathematical models could determine the relationship between clinical‐obstetric characteristics and CS. These models generated probabilities of CS that could be compared with the observed CS rates. We devised a three‐step approach to generate the global benchmark of CS rates at health facilities: creation of a multi‐country reference population, building mathematical models, and testing these models.Main outcome measures: Area under the ROC curves, diagnostic odds ratio, expected CS rate, observed CS rate.Results: According to the different versions of the model, areas under the ROC curves suggested a good discriminatory capacity of C‐Model, with summary estimates ranging from 0.832 to 0.844. The C‐Model was able to generate expected CS rates adjusted for the case‐mix of the obstetric population. We have also prepared an e‐calculator to facilitate use of C‐Model (www.who.int/reproductivehealth/publications/maternal_perinatal_health/c-model/en/).Conclusions: This article describes the development of a global reference for CS rates. Based on maternal characteristics, this tool was able to generate an individualised expected CS rate for health facilities or groups of health facilities. With C‐Model, obstetric teams, health system managers, health facilities, health insurance companies, and governments can produce a customised reference CS rate for assessing use (and overuse) of CS.Tweetable The C‐Model provides a customized benchmark for caesarean section rates in health facilities and systems.

1 October 2017 in Vaccine
Verified
Journal Article
Open access
DFDeshayne B. Fell
Deshayne B. Fell
EAEduardo Azziz-Baumgartner
Eduardo Azziz-Baumgartner
MBMichael Baker
Michael Baker
MBManeesh Batra
Maneesh Batra
JBJulien Beauté
Julien Beauté
JOJustin R. Ortiz
Justin R. Ortiz
From 2014 to 2017, the World Health Organization convened a working group to evaluate influenza disease burden and vaccine efficacy to inform estimates of maternal influenza immunization program impact. The group evaluated existing systematic reviews and relevant primary studies, and conducted four new systematic reviews. There was strong evidence that maternal influenza immunization prevented influenza illness in pregnant women and their infants, although data on severe illness prevention were lacking. The limited number of studies reporting influenza incidence in pregnant women and infants under six months had highly variable estimates and underrepresented low- and middle-income countries. The evidence that maternal influenza immunization reduces the risk of adverse birth outcomes was conflicting, and many observational studies were subject to substantial bias. The lack of scientific clarity regarding disease burden or magnitude of vaccine efficacy against severe illness poses challenges for robust estimation of the potential impact of maternal influenza immunization programs.

1 December 2015 in Clinics
Verified
Journal Article
Open access
JSJuliana P Santos
Juliana P Santos
JCJose Guilherme Cecatti
Jose Guilherme Cecatti
SSSuzanne J Serruya
Suzanne J Serruya
PAPaulo V Almeida
Paulo V Almeida
PDPablo Duran
Pablo Duran
CPCynthia Pileggi-Castro
Cynthia Pileggi-Castro
In Latin American, there is currently a regional action with the main purposes of putting the concept of severe neonatal morbidity in practice and formulating proposals for interventions. A general overview of neonatal health conditions, including morbidity and mortality, is provided to update regional knowledge on the topic. An example of the development and implementation of the concept of maternal near miss is also provided, followed by results from a systematic review covering all previously published studies on Neonatal Near Miss. Finally, some proposals for building a common concept on the topic and for launching a prospective surveillance study are presented. A Neonatal Near Miss is a neonate who had a severe morbidity (organ dysfunction or failure) but who survived this condition within the first 27 days of life. The pragmatic criteria recommended to be used are as follows: birth weight below 1700 g, Apgar score below 7 at 5 minutes of life and gestational age below 33 weeks. As a proxy for organ dysfunction, the following management criteria are also confirmed: parenteral therapeutic antibiotics; nasal continuous positive airway pressure; any intubation during the first 27 days of life; phototherapy within the first 24 h of life; cardiopulmonary resuscitation; the use of vasoactive drugs, anticonvulsants, surfactants, blood products and steroids for refractory hypoglycemia and any surgical procedure. Although this study starts from a regional perspective, this topic is clearly globally relevant. All nations, especially low and middle-income countries, could benefit from the proposed standardization.

24 September 2015 in BJOG: An International Journal of Obstetrics & Gynaecology
Verified
Journal Article
Open access
PDF file
LMLE Mignini
LE Mignini
GCG Carroli
G Carroli
ABAP Betran
AP Betran
RFR Fescina
R Fescina
CCC Cuesta
C Cuesta
KKKs Khan
Ks Khan
Objective: To determine the relationship of interpregnancy interval with maternal and offspring outcomes.Design: Retrospective study with data from the Perinatal Information System database of the Latin American Centre for Perinatology and Human Development, Uruguay.Setting: Latin America, 1990–2009.Population: A cohort of 894 476 women delivering singleton infants.Methods: During 1990–2009 the Perinatal Information System database of the Latin American Centre for Perinatology identified 894 476 women with defined interpregnancy intervals: i.e. the time elapsed between the date of the previous delivery and the first day of the last normal menstrual period for the index pregnancy. Using the interval 12–23 months as the reference category, multiple logistic regression estimated adjusted odds ratios (aORs) with 95% confidence intervals (95% CIs) of the association between various interval lengths and maternal and offspring outcomes.Main outcome measures: Maternal death, pre‐eclampsia, eclampsia, puerperal infection, fetal death, neonatal death, preterm birth, and low birthweight.Results: In the reference interval there was 0.05% maternal death, 1.00% postpartum haemorrhage, 2.80% pre‐eclampsia, 0.15% eclampsia, 0.28% puerperal infection, 3.45% fetal death, 0.68% neonatal death, 12.33% preterm birth, and 9.73% low birthweight. Longer intervals had increased odds of pre‐eclampsia (>72 months), fetal death (>108–119 months), and low birthweight (96–107 months). Short intervals of <12 months had increased odds of pre‐eclampsia (aOR 0.80; 95% CI 0.76–0.85), neonatal death (aOR 1.18; 95% CI 1.08–1.28), and preterm birth (aOR 1.16; 95% CI 1.11–1.21). Statistically, the interval had no relationship with maternal death, eclampsia, and puerperal infection.Conclusions: A short interpregnancy interval of 72 months are associated with pre‐eclampsia, fetal death, and low birthweight, but not with other maternal or offspring outcomes.Tweetable A short interpregnancy interval of <12 months is associated with neonatal mortality and preterm birth.

30 August 2019 in International Journal of Gynecology & Obstetrics
Verified
Journal Article
Closed access
PDF file
BMBremen De Mucio
Bremen De Mucio
SSSuzanne Serruya
Suzanne Serruya
AAAlicia Alemán
Alicia Alemán
GCGraciela Castellano
Graciela Castellano
CSClaudio G. Sosa
Claudio G. Sosa

4 November 2016 in Reproductive Health
Verified
Journal Article
Open access
PDF file
T(the Latin American Near Miss Group (LANe-MG)
the Latin American Near Miss Group (LANe-MG)
BMBremen De Mucio
Bremen De Mucio
EAEdgardo Abalos
Edgardo Abalos
CCCristina Cuesta
Cristina Cuesta
GCGuillermo Carroli
Guillermo Carroli
JSJoão Paulo Souza
João Paulo Souza
Every year millions of women around the world suffer from pregnancy, childbirth and postpartum complications. Women who survive the most serious clinical conditions are regarded as to have experienced a severe acute maternal complication called maternal near miss (MNM). Information about MNM cases may complement the data collected through the analysis of maternal death, and was proposed as a helpful tool to identify strengths and weaknesses of health systems in relation to maternal health care. The purpose of this study is to evaluate the performance of a systematized form to detect severe maternal outcomes (SMO) in 20 selected maternity hospitals from Latin America (LAC). Cross-sectional study. Data were obtained from analysis of hospital records for all women giving birth and all women who had a SMO in the selected hospitals. Univariate and multivariate adjusted logistic regression models were used to assess the predictive ability of different conditions to identify SMO cases. In parallel, external auditors were hired for reviewing and reporting the total number of discharges during the study period, in order to verify whether health professionals at health facilities identified all MNM and Potentially life-threatening condition (PLTC) cases. Twenty hospitals from twelve LAC were initially included in the study and based on the level of coverage, 11 hospitals with a total of 3,196records were included for the final analysis. The incidence of SMO and MNM outcomes was 12.9 and 12.3 per 1,000 live births, respectively. The ratio of MNM to maternal death was 19 to 1, with a mortality index of 5.1 %. Both univariate and multivariate analysis showed a good performance for a number of clinical and laboratory conditions to predict a severe maternal outcome, however, their clinical relevance remains to be confirmed. Coherence between health professionals and external auditors to identify SMO was high (around 100 %). The form tested, was well accepted by health professionals and was capable of identifying 100 % of MNM cases and more than 99 % of PLTC variables. Altered state of consciousness, oliguria, placenta accrete, pulmonary edema, and admission to Intensive Care Unit have a high (LR+ ≥80) capacity to anticipate a SMO.